Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD.
Hiremath S, McGuinty M, Argyropoulos C, Brimble KS, Brown PA, Chagla Z, Cooper R, Hoar S, Juurlink D, Treleaven D, Walsh M, Yeung A, Blake P. Hiremath S, et al. Among authors: mcguinty m. Clin J Am Soc Nephrol. 2022 Aug;17(8):1247-1250. doi: 10.2215/CJN.05270522. Epub 2022 Jun 9. Clin J Am Soc Nephrol. 2022. PMID: 35680135 Free PMC article. No abstract available.
Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019.
Hiremath S, Blake PG, Yeung A, McGuinty M, Thomas D, Ip J, Brown PA, Pandes M, Burke A, Sohail QZ, To K, Blackwell L, Oliver M, Jain AK, Chagla Z, Cooper R. Hiremath S, et al. Among authors: mcguinty m. Clin J Am Soc Nephrol. 2023 Apr 1;18(4):485-490. doi: 10.2215/CJN.0000000000000107. Epub 2023 Mar 1. Clin J Am Soc Nephrol. 2023. PMID: 36723285 Free PMC article. Clinical Trial.
A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.
Cowan J, Mulpuru S, Abdallah SJ, Chopra A, Purssell A, McGuinty M, Alvarez GG, Giulivi A, Corrales-Medina V, MacFadden D, Boyle L, Hasimja D, Thavorn K, Mallick R, Aaron SD, Cameron DW. Cowan J, et al. Among authors: mcguinty m. Int J Chron Obstruct Pulmon Dis. 2021 Dec 3;16:3275-3284. doi: 10.2147/COPD.S338849. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34887657 Free PMC article. Clinical Trial.
Symptoms, Pulmonary Function, and Functional Capacity Four Months after COVID-19.
Abdallah SJ, Voduc N, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A, Law A, Garuba HA, Thavorn K, Reid RER, Lavoie KL, Crawley A, Chirinos JA, Cowan J. Abdallah SJ, et al. Among authors: mcguinty m. Ann Am Thorac Soc. 2021 Nov;18(11):1912-1917. doi: 10.1513/AnnalsATS.202012-1489RL. Ann Am Thorac Soc. 2021. PMID: 33872135 Free PMC article. No abstract available.
Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity.
McGuinty M, Angel JB, Cooper CL, Cowan J, MacPherson PA, Kumar A, Murthy S, Sy R, Dennehy M, Tremblay N, Byrareddy SN, Cameron DW. McGuinty M, et al. BMJ Open. 2020 Oct 8;10(10):e041359. doi: 10.1136/bmjopen-2020-041359. BMJ Open. 2020. PMID: 33033101 Free PMC article.
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2.
Galipeau Y, Siragam V, Laroche G, Marion E, Greig M, McGuinty M, Booth RA, Durocher Y, Cuperlovic-Culf M, Bennett SAL, Crawley AM, Giguère PM, Cooper C, Langlois MA. Galipeau Y, et al. Among authors: mcguinty m. EBioMedicine. 2021 Dec;74:103700. doi: 10.1016/j.ebiom.2021.103700. Epub 2021 Nov 30. EBioMedicine. 2021. PMID: 34861490 Free PMC article.
19 results